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Objectives: With recent advances in nanoparticle manufacturing and applications, potential exposure to nanoparticles in various settings is becoming increasing likely. No investigation has yet been performed to assess whether respiratory tract exposure to cerium
oxide (CeO2) nanoparticles is associated with alterations in protein signaling, inflammation, and apoptosis in rat lungs.
Methods: Specific-pathogen-free male Sprague-Dawley rats were instilled with either vehicle (saline) or CeO2 nanoparticles at a dosage of 7.0 mg/kg and euthanized 1, 3, 14, 28, 56, or 90 days after exposure. Lung tissues were collected and evaluated for the expression of proteins associated with inflammation and cellular apoptosis.
Results: No change in lung weight was detected over the course of the study; however, cerium accumulation in the lungs, gross histological changes, an increased Bax to Bcl-2 ratio, elevated cleaved caspase-3 protein levels, increased phosphorylation of p38 MAPK,
and diminished phosphorylation of ERK-1/2-MAPK were detected after CeO2 instillation (p<0.05).
Conclusions: Taken together, these data suggest that high-dose respiratory exposure to CeO2 nanoparticles is associated with lung
inflammation, the activation of signaling protein kinases, and cellular apoptosis, which may be indicative of a long-term localized inflammatory response.
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Cerium is a lanthanide metal that can undergo redox cycling
depending on the partial pressure of oxygen in the surrounding environment [1]. The industrial production and utilization
of cerium oxide (CeO2) nanoparticles is increasing rapidly in the
polishing, energy, electronic, automobile, and biomedical industries [2]. Recently, CeO2 nanoparticles have been used as
catalysts in combustion engines to reduce particulate emis-
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sions and increase fuel efficiency [3]. Other work has demonstrated that CeO2 nanoparticles may exhibit antioxidant activity
[4], which has led to the suggestion that these particles may be
useful for the treatment of cardiovascular disease [5], neuronal
injury [6], and the prevention of radiation-induced damage [7].
In addition to the beneficial applications of CeO2 nanoparticles, some researchers have begun to examine whether these
materials may also be toxic. In vitro studies using lung cancer
cells (A549) [8] and bronchoalveolar epithelial cells (BEAS2B) [9]
have suggested that cellular exposure to CeO2 nanoparticles
may be associated with the increased production of reactive
oxygen species and the induction of cellular apoptosis. Other
work using intact rats has demonstrated that exposure to CeO2
nanoparticles can cause lung inflammation and fibrosis [1012]. How exposure to CeO2 nanoparticles may induce lung inflammation and remodeling has not been fully elucidated.
Mitogen-activated protein kinases (MAPKs), including the extracellular signal-regulated kinase (ERK)-1/2-MAPK, p38 MAPK,
and c-Jun amino terminal kinase (JNK), are a family of serine/
threonine-specific kinases that transduce extracellular stimuli
and are involved in the regulation of cell proliferation, gene expression, and apoptosis [13,14]. Previous work has suggested
that several metals, including arsenic, zinc, and chromium, can
induce the phosphorylation of MAPK proteins [15]. To the best
of our knowledge, no studies have yet investigated whether exposure to CeO2 nanoparticles can elicit similar activity.
The primary goal of this study was to determine if exposure
to CeO2 nanoparticles is associated with the activation of MAPK
signaling and cellular apoptosis in the lungs of intact rats. Our
data suggest that exposure to CeO2 nanoparticles is associated
with cerium accumulation in the lungs, an increased Bax to Bcl2 ratio, elevated caspase-3 protein levels, increased phosphorylation of p38 MAPK, and diminished phosphorylation of ERK1/2-MAPK (p<0.05). Taken together, these data suggest that exposure to CeO2 nanoparticles is associated with activation of
MAPK signaling along with cellular apoptosis.

METHODS
Particle Characterization
CeO2 nanoparticles with an average hydrodynamic diameter
of approximately 20 nm and average physical diameter of approximately 10 nm were obtained from Sigma-Aldrich (St. Louis, MO, USA), corresponding to the specifications of nanoparticles used in previous experiments [12]. Normal saline was used

to suspend the nanoparticles prior to instillation. Diluted particle suspensions were filtered, sputter-coated, and examined
with a Hitachi Model S-4800 Field Emission scanning electron
microscope (Schaumburg, IL, USA) at 5 kV and 20 kV, or placed
on a formvar-coated copper grid to dry and imaged with a
JEOL 1220 transmission electron microscope (Tokyo, Japan), as
previously described [16].

Animal Handling and Instillation of Cerium Oxide
Nanoparticles
All procedures were performed in accordance with the Marshall University Animal Care and Use Committee guidelines, using the criteria outlined by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC). Five-weekold (150 to 174 g) specific-pathogen-free male Sprague-Dawley (Hla: SD-CVF) rats were purchased from Hilltop Lab Animals,
Inc. (Scottdale, PA, USA). Rats were housed two per cage in an
AAALAC-approved vivarium with a 12-hour light-dark cycle
and maintained at 22±2˚C. Animals were allowed access to
food and water ad libitum. All animals were allowed to acclimatize for two weeks before the study began. All animals were examined for precipitous weight loss, failure to thrive, or unexpected gait. Periodic weight measurements were taken throughout the duration of the study.
After acclimatization, the animals were randomly divided
into 12 groups (n=6 per group). After anesthetization, the animals were placed on an inclined restraint board and instilled
with 0.3 mL of a saline suspension of CeO2 nanoparticles at a
dosage of 7.0 mg/kg or 0.3 mL of saline, as described elsewhere
[16]. This dose was selected based on previously published data
by Ma et al. [17] demonstrating a dose-dependent response in
lung cells.

Tissue Collection
Rats were anesthetized at 1, 3, 14, 28, 56, or 90 days post-exposure, using a ketamine (40 mg/kg) and xylazine (10 mg/kg)
cocktail (administered intraperitoneally), supplemented as
necessary to ensure the loss of reflexive responses. After midline laparotomy, the lungs were removed and placed in KrebsRinger bicarbonate buffer, containing 118 mM NaCl, 4.7 mM
KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 24.2 mM
NaHCO3, and 10 mM α-D-glucose (pH 7.4), equilibrated with 5%
CO2/95% O2, and maintained at 37˚C. Blood and other tissue
materials were removed from the isolated lungs, weighed immediately, and snap-frozen in liquid nitrogen.
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Determination of Cerium Content in the Lungs
Cerium content in the lungs was estimated by induction coupled plasma-mass spectrometry (ICP-MS) at Elemental Analysis,
Inc. (Lexington, KY, USA) according to standard protocols as described elsewhere [16]. The cerium concentration was estimated
for the 1, 3, 14, 28, and 90-day post-exposure groups. Briefly,
lung samples (n=4 for each group) were prepared using the Environmental Protection Agency method 3050B for the analysis of
total cerium by ICP-MS. Samples was weighed and digested with
concentrated nitric acid, concentrated hydrochloric acid, and
30% hydrogen peroxide. Samples were diluted and compared
against a laboratory control sample using an Agilent 7500cx ICPMS machine (Agilent Technologies, Santa Clara, CA, USA).

ERK-1/2 Thr 202/Tyr204 (1:1000 dilution in 5% BSA in TBST)
(#9106S), phosphorylated ERK-1/2 (1:1000 dilution in 5% BSA
in TBST) Thr 202/Tyr204 (#4377S), JNK (1:500 dilution in 5% BSA
in TBST) (#9252), phosphorylated JNK Thr 183/Tyr185 (1:500 dilution in 5% BSA in TBST) (#9251S), p38 MAPK (1:1000 dilution
in 5% BSA in TBST) (#9212), phosphorylated p38 MAPK Thr 180/
Tyr 182 (1:1000 dilution in 5% BSA in TBST) (#9216L), JAK-2
(1:1000 dilution in 5% BSA in TBST) (#3229), phosphorylated
JAK-2 Tyr 1007/100 (1:1000 dilution in 5% BSA in TBST) (#3776),
STAT-3 (1:500 dilution in 5% BSA in TBST) (#9132), and phosphorylated STAT-3 Tyr 705 (1:500 dilution in 5% BSA in TBST)
(#9131S) were purchased from Cell Signaling Technology (Beverly, MA, USA).

Histopathological Examination

Data Analysis

Histopathological examination was performed on lungs from
the day 1 saline control group, and in groups that had been exposed to CeO2 for 1, 3, 14, and 28 days, using hematoxylin-eosin (H&E) staining on formalin-fixed lung tissues. Using standard histopathological techniques lung tissues were embedded in paraffin wax, sectioned at 5 μm, mounted on glass
slides, and stained with H&E. In a blinded fashion, sections
were examined by light microscopy by a board-certified pathologist.

Data were analyzed using the SigmaPlot version 11.0 (Systat
Software Inc., San Jose, CA, USA). Results are presented as
mean±standard error of the mean. To determine overall comparisons one-way analysis of variance and two-way analysis of
variance were performed, followed by a Student-Newman-Keuls
post hoc test to determine differences between groups. A p-value <0.05 was considered statistically significant.

Immunoblotting Analysis

Nanoparticle Characterization

Portions of individual lung tissues (100 to 150 mg) were homogenized in lysis buffer (T-PER, 8 mL/g of tissue; Pierce, Rockford, IL, USA) containing phosphatase inhibitors (Sigma-Aldrich)
and protease (Sigma-Aldrich). Tissue homogenates were sonicated for three cycles for 30 seconds at 150 W. The supernatant
protein was collected by centrifuging the tissue homogenate at
12 000×g for five minutes at 4˚C. The protein concentration of
homogenates was determined via the 660-nm assay method
(Fisher Scientific, Rockford, IL, USA). Equal concentrations of the
protein samples were prepared from individual animals by adding equal quantities of Laemmli 2X sample buffer (Sigma-Aldrich) and adjusting the protein concentration with the T-PER
lysis buffer. Immunoblotting was performed on the prepared
samples as described in Kakarla et al. [18] using the primary antibodies against caspase-3 (1:1000 dilution in 5% bovine serum
albumin [BSA] in TBST) (#9662), cleaved caspase-3 (1:500 dilution in 5% BSA in TBST) (#9661S), Bax (1:1000 dilution in 5%
BSA in TBST) (#2772), Bcl2 (1:1000 dilution in 5% BSA in TBST)
(#2870S), caspase-9 (1:1000 dilution in 5% BSA in TBST) (#9506),

Similar to previous research [12,16] using CeO2 nanoparticles
made to the same specifications, the analysis of nanoparticle
size by scanning electron microscopy and transmission electron microscopy confirmed the presence of single and agglomerated CeO2 nanoparticles in the suspension. Field emission
scanning electron microscopy showed submicron groups dispersion of CeO2 nanoparticles with an average size of 9.26±
0.58 nm. Determination of the diameter of the primary CeO2
particles was 10.14±0.76 nm when evaluated by transmission
electron microscopy.
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RESULTS

Accumulation of Cerium in the Lung Over Time
After Exposure
The concentration of cerium in the lungs was estimated using
ICP-MS (Elemental Analysis). The concentration of cerium in the
lungs decreased as post-exposure time increased. The concentration of cerium in lung tissue at 14, 28, and 90 days post-exposure was significantly lower than in tissue obtained one day after exposure to CeO2 nanoparticles, as shown in Figure 1.

Cerium Oxide Nanoparticle Exposure Activates MAPK in Rat Lungs

Exposure to Cerium Oxide Nanoparticles Alters
the Gross Histological Appearance of the Lung
Alterations in the appearance of the lungs following exposure
included the presence of areas of black discoloration and white
pustular nodules on the surface of the lungs, which appeared
to increase over time (Figure 2). Histological alterations included an increased number of alveolar macrophages, an increased
number of polymorphonuclear cells, and an apparent accumulation of particulate material in the alveolar spaces (Figure 3).

ratio in exposed animals was 99% higher three days after exposure (p<0.05) before declining thereafter. Compared to the
day 1 saline control group, the Bax to Bcl-2 ratio was 37, 23, and
14% lower at days 14, 28, and 56, respectively, in animals ex-

Cerium Oxide Nanoparticles Increase Apoptotic
Protein Signaling in the Lung
Compared to the day 1 saline control group, the Bax to Bcl-2
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Figure 1. Cerium concentration in the lungs appears to diminish over time. Lung tissues (approximately 1 g) were used for estimation of the cerium content in the lungs through induction
couple plasma-mass spectrometry analysis. Con-1 represents
the day 1 saline control group, while CeO2-1, 3, 14, 28, and 90
represent the groups exposed to cerium oxide (CeO2) nanoparticles for 1, 3, 14, 28, and 90 days respectively. One-way analysis
of variance was performed for overall comparisons, while the
Student-Newman-Keuls post hoc test was used to determine
differences between groups. *p<0.05 between the day 1 saline
control group, †p<0.05 between the CeO2 day 1 group.

A

B

Figure 2. Gross alterations in the lungs with exposure to cerium oxide (CeO2) nanoparticles include increased weight,
black discoloration of the lungs, and the appearance of white
nodules on the surface. The white nodules appeared to increase with longer exposure, and the white nodules appeared
to coalesce to form bigger nodules at day 90. (A) Saline control
lungs day 1, (B) CeO2 exposed lungs (7.0 mg/kg) day 28, (C)
CeO2 exposed lungs (7.0 mg/kg) day 56, and (D) CeO2 exposed
lungs (7.0 mg/kg) day 90.

C

D

E

Figure 3. Alterations in the histological appearance of lungs associated with the instillation of CeO2 nanoparticles include an increased number of alveolar macrophages, an increase in the number of polymorphonuclear white blood cells (short arrow), and
the increased accumulation of particulate matter (long arrow) in the air spaces (400×). (A) Saline control-1 H&E lung 400X, (B)
CeO2-1 H&E lung 400X, (C) CeO2-3 H&E lung 400X, (D) CeO2-14 H&E lung 400X, and (E) CeO2-28 H&E lung 400X. CeO2, cerium oxide; H&E, hematoxylin and eosin; CeO2-n, lung tissues from the groups that had been exposed to CeO2 nanoparticles for n days.
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posed to CeO2 nanoparticles (p<0.05) (Figure 4).
In order to extend these findings, we next examined the regulation of the initiator (caspase-9) and the executor caspases
(caspase-3) [18]. Compared to the day 1 saline control group,
the total caspase-9 protein levels were reduced by 28, 6, 23, 21,
and 32% in the 1, 3, 14, 56, and 90-day post-exposure groups
(p<0.05). Compared to the day 1 saline control group, the expression of the 38-kDa and 40-kDa cleaved fragments of caspase-9 was increased by 20% in the 3, 14, and 28-day post-exposure groups (p<0.05) (Figure 4).
Caspase-3 protein expression levels increased by 56%
(p<0.05) and 20% (p<0.05) in the 3 and 14-day exposure
groups, when compared to the day 1 saline control group.
Compared to the day 1 saline control group, the protein expression of the cleaved fragments of caspase-3 (17 kDa and 19 kDa)
were increased by 10, 88, 66, 119, 77, and 39% in the 1, 3, 14,
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Figure 4. Cerium oxide (CeO2) nanoparticles increase proapoptotic protein signaling in the lungs. Protein bands of the
Bax, Bcl-2 (A), caspase-9, cleaved caspase-9 (B), and caspase-3, cleaved caspase-3 (C) proteins, along with the corresponding glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels, are represented in the figure. Bands corresponding to the X-axis labels are shown in the immunoblotting images. The protein levels were adjusted depending on the
GAPDH levels and compared with the day 1 control group.
One-way analysis of variance was performed for overall comparisons, while the Student-Newman-Keuls post hoc test was
used to determine differences between groups. *p<0.05 between the day 1 saline control group.

28, 56, and 90-day post-exposure groups (p<0.05) (Figure 4).

Cerium Oxide Nanoparticle Exposure Is Associated With Activation of Mitogen-activated Protein Kinase Signaling
Compared to the day 1 saline control group, the ratio of phosphorylated p38 MAPK (Thr180/Tyr182) to total p38 MAPK was
reduced by 22 and 14% in the day 1 and day 3 post-exposure
groups (p<0.05). However, this ratio was elevated by 52, 15, and
10% in the 14, 28, and 56-day post-exposure groups, before it
declined by 19% in the 90-day post-exposure group (p<0.05)
(Figure 5).
The ratio of phosphorylated ERK-1/2 (Thr202/Tyr204) to total
ERK-1/2 was reduced by 43, 57, 56, 62, 53, and 41% in the 1, 3,
14, 28, 56, and 90-day post-exposure groups compared to the
day 1 saline control group (p<0.05) (Figure 5). In contrast, the
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ratio of phosphorylated (Thr183/Tyr185) JNK to total JNK was
unaltered following nanoparticle exposure (Figure 5).

Cerium Oxide Nanoparticles Activate Inflammatory Protein Signaling Through p38 MAPK Mediated STAT-3 Activation
It is known that JAK-2 and STAT-3 play a crucial role in inflammation [19]. When compared to the day 1 saline control group,
the ratio of phosphorylated (Tyr705) to total STAT-3 protein was
111, 193, and 106% higher at 3, 14, and 28 days after exposure
(p<0.05) (Figure 6). The ratio of phosphorylated (Tyr1007/1008)
JAK-2 to total JAK-2 was 25 and 103% higher in the 1 and 90day post-exposure groups compared to the control animals (p<
0.05) (Figure 6).

DISCUSSION
Previous In vitro and in vivo studies have suggested that exposure to CeO2 nanoparticles can elicit toxic effects, although
the underlying mechanism is not well understood [3,8,12,20].
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Figure 5. Activation of mitogen-activated protein kinase
(MAPK) protein signaling was observed with the instillation of
cerium oxide (CeO2) nanoparticles. Protein bands of the p38
MAPK, phosphorylated p38 MAPK (A), ERK-1/2-MAPK, phosphorylated ERK-1/2-MAPK (B), and JNK, phosphorylated JNK
(C) proteins, along with the corresponding glyceraldehyde
3-phosphate dehydrogenase (GAPDH) levels are represented
in the figure bands corresponding to the X-axis labels and are
shown in the immunoblotting images. Protein levels were adjusted according to the GAPDH levels and compared with the
day 1 control group. One-way analysis of variance was performed for overall comparisons, while the Student-NewmanKeuls post hoc test was used to determine differences between groups. *p <0.05 between the day 1 saline control
group.

The primary finding of the current study is that pulmonary exposure to CeO2 nanoparticles is associated with histological
evidence of lung inflammation, the activation of MAPK signaling, the phosphorylation of STAT-3, increased caspase-3 cleavage, and inflammation.
The data from the current study show that the instillation of
CeO2 nanoparticles leads to the deposition of cerium in the
lungs, as shown by ICP-MS (Figure 1). We also observed that
exposure to CeO2 nanoparticles was associated with the development of white nodular structures on the lung surface (Table
1, Figures 2 and 3). Recent work has shown that nanoparticles
such as carbon nanotubes, titanium dioxide nanoparticles, and
polyacrylate nanoparticles can induce granulomas on the lung
surface [21-23]. It is possible that the white nodules we observed in the present study may be the byproduct of an ongoing inflammatory reaction, which could result in either the
clearance of the nanoparticles or their further development
into granulomas on the surface of the lungs [22,24]. The aforementioned possibility is consistent with our histopathological
analysis, in which we observed an increase in the number of al-
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Table 1. Cerium oxide (CeO2) nanoparticle exposure increases the ratio of lung weight to body weight
Exposure (d)

Body weight (g)

Lung weight (g)

Saline control

CeO2 (7.0 mg/kg)

Saline control

CeO2 (7.0 mg/kg)

1

319.67±15.92

319.67±15.20

1.74±0.28

1.88±0.08

3

310.33±28.10

331.67±24.00

1.54±0.27

2.19±0.15

14

345.67±27.11

332.33±21.07

1.90±0.31

2.12±0.23

28

411.33±29.2

403.67±28.94

1.82±0.09

2.43±0.30

56

451.67±26.211-3

451.00±34.61-4

1.56±0.24

2.84±0.58

90

523.33±60.871-5

519.33±44.841-5

1.62±0.11

2.75±0.51

1,3

1,3

Lung tissues were collected from groups of animals that were intratracheally instilled with either normal saline or CeO2 nanoparticles at a dosage of 7.0 mg/kg,
at 1, 3, 14, 28, 56, and 90 days after exposure. The lung tissues were cleaned to remove blood and tissue debris with Krebs’s lactate solution and weighed immediately (n=6/group). Two-way analysis of variance was performed for overall comparisons, while the Student-Newman-Keuls post hoc test was used to determine differences between groups; p<0.05 were considered to indicate statistical significance.
1
Significantly different from the one-day exposure group for a given condition.
2
Significantly different from the three-day exposure group for a given condition.
3
Significantly different from the 14-day exposure group for a given condition.
4
Significantly different from the 28-day exposure group.
5
Significantly different from the 56-day exposure group.

veolar macrophages and polymorphonuclear white blood cells
in the lungs of animals that had been exposed to CeO2 nanoparticles. It is thought that the toxic effects of most nanoparticles
(silver, silica, titanium dioxide, zinc oxide, and carbonaceous
nanoparticles) are characterized by increased oxidative stress
[25-29]. Whether these increases in oxidative stress are due to increased reactive oxygen species (ROS) generation or decreased
ROS scavenging is currently unclear, although many metallic oxide nanoparticles have been shown to increase ROS production
[30,31].
Increased ROS levels may also induce apoptotic signaling. We
observed an increase in the pro-apoptotic Bax to Bcl-2 ratio at
one and three days after the exposure to CeO2 nanoparticles,
with a subsequent decline. Since the Bax to Bcl-2 ratio is an indicator of whether a cell is likely to undergo apoptosis [18,32],
we next examined the possibility that CeO2 nanoparticle exposure may be associated with the activation of caspase-3. Consistent with the Bax/Bcl-2 data, we found that caspase-3 cleavage (activation) was elevated at 3, 14, 28, and 56 days post-exposure. Why caspase-3 cleavage was present in the absence of
an elevated Bax/Bcl-2 ratio is currently unclear. Other signaling
pathways (extrinsic or intrinsic pathways) that activate the
apoptotic pathway may be in play and explain the possible activation of effector caspase-3 in the absence of an elevated
Bax/Bcl-2 ratio. It is thought that mild lung injury may elicit the
repair of the damaged tissue, whereas excessive apoptosis-induced cell death may lead to the development of lung remodeling and fibrosis [33]. Bearing this in mind, the activation of
caspase-3 we identified in the current study may help to ex-
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plain previous findings that increased lung fibrosis follows exposure to CeO2 nanoparticles [12].
MAPKs are stress-responsive proteins that can be activated
by growth factors, chemicals, ultraviolet radiation, heat, synthesis inhibitors, metals, or foreign organisms [34]. MAPK pathways have been shown to play important roles in oxidative
stress and inflammation induced by nanoparticles and metals
[15,31]. The three primary members of the MAPK signaling
modules are the p38, JNK, and ERK-1/2 MAPKs. MAPK proteins
are thought to phosphorylate (activate) transcription factors
that are involved in regulating both cell survival and cell death.
In the present study, exposure to CeO2 nanoparticles was associated with increased phosphorylation of p38 MAPK at 14, 28,
and 56 days after exposure. Conversely, we found that ERK1/2-MAPK activity appeared to be impaired by CeO2 nanoparticles (Figure 5). Since ERK-1/2-MAPK is thought to play an important role in cell survival and p38 MAPK may play an important role in apoptosis [34], these differences in MAPK signaling
may help to explain the sustained caspase-3 cleavage after
the pro-apoptotic Bax to Bcl-2 ratio returned to normal.
It is well known that nanoparticle exposure is often associated with increased levels of cytokines, interleukins, and other
mediators of inflammation. The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is a particularly important pathway in mediating inflammation [19].
Interestingly, JAK-2 did not appear to play an important role in
the toxicological response, as its phosphorylation (Tyr1007/
1008) was elevated only at day 1 and day 90 (Figure 6). Conversely, the phosphorylation of STAT-3 (Tyr705) seemed to
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Figure 6. Activation of STAT-3 after exposure to cerium oxide (CeO2) nanoparticles follows the activation of p38 MAPK. The protein
bands of the STAT-3, phosphorylated STAT-3 (A) and JAK-2, phosphorylated JAK-2 (B) proteins, along with the corresponding glyceraldehyde 3-phosphate and dehydrogenase (GAPDH) values, are represented in the figure. The bands corresponding to the X-axis labels are shown in the immunoblotting images. The protein levels were adjusted according to the GAPDH levels and compared
with the day 1 control. One-way analysis of variance was performed for overall comparisons, while the Student-Newman-Keuls
post hoc test was used to determine differences between groups. *p<0.05 between the day 1 saline control group.

parallel p38 MAPK activation (Figure 6). A previous study has
demonstrated that p38 MAPK can act as an upstream activator of STAT-3, which, in turn, can induce apoptosis when activated [35]. Other research has shown that the p38 MAPK and
STAT-3 signaling pathways can work in concert or separately
to exert apoptotic effects on the cells [36]. These data, considered in light of our findings regarding the increased Bax to Bcl2 ratio, are consistent with the possibility that apoptosis mediated by CeO2 nanoparticles is mediated through the activation
of the p38 MAPK and STAT-3 signaling pathways.
In summary, our data suggest that lung exposure to CeO2
nanoparticles is associated with the increased accumulation
of cerium in the lungs and gross pathological and histological
alterations to the lungs. It also appears that CeO2 nanoparticles can induce inflammation and apoptotic protein signaling
in the lungs. Overall, the data from the current study indicate
that CeO2 nanoparticle-induced inflammation and apoptosis
may be mediated through the activation of the stress-responsive MAPK protein signaling pathway, the phosphorylation of
STAT-3, and the activation of the intrinsic apoptosis pathway
(Figure 6). Given these findings, additional research to evaluate the role of subcellular organelles in inducing apoptosis in
these conditions is likely warranted.
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